Sangamo Therapeutics, Inc. 2021 Q1 - Results - Earnings Call Presentation

The following slide deck was published by Sangamo Therapeutics, Inc. in conjunction with their 2021 Q1 earnings call.

Comments

[San Marzano]

The only worse company in the space, IONS. Two bottom feeders!

[mlnovillo]

Typical Sangamo....oblivious to their shareholders. If I shorted biotech SGMO would be the first company i'd short.

[jeybolt00]

This is a very frustrating company to own. Lots of shots on net but a long way to go. My guess is they need to raise cash again before they see meaningful revenue. Only one phase 3 trial and splitting the pie with Pfizer. Splitting the pie with everyone in fact, which they consider “validating.” I’ve been long a long time here but ready to cut bait. Given all the tie ins with various pharma companies I suspect buyout is unlikely. Good luck to those who stay long I may take what little profits I have and run.

[MoneyPro]

@jeybolt00 RBC just gave them an "Outperform"